reported that compound A30 displays outstanding PKMYT1 kinase inhibitory activity ((IC50) = 0.003 μM) and exerts strong anti‐proliferative effects in CCNE1‐amplified tumour cells. This evidence concerns the gene PKMYT1 and neoplasm.